ReviewCurrent medicinal chemistry2025
Anti-cancer Properties of Epigallocatechin-3-gallate (EGCG) and its Signaling Pathways.
Review in Current medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bone Marrow Stem Cell Exosomes Protect Lung Cells from Oxygen Damage by Regulating miR-23a-3p/Slc7a2 Pathway.The journal of gene medicine · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green tea is a traditional drink found in Asian countries, made up of four derivatives. One of the derivatives is epigallocatechin-3-gallate (EGCG). EGCG provides therapeutic benefits for cancer, heart disease, diabetes, and obesity. However, its poor absorption and instability limit its effectiveness, which can be improved using nanoparticle encapsulation. This work is a comprehensive review of the studies on green tea polyphenols, the impact of pro-oxidants and EGCG in cancer prevention, and their delivery using nanotechnology. Other plant sources of ellagitannin and its physicochemical properties, the therapeutic and preventive role of EGCG in breast cancer, and other cancers that can be treated using nano gold (NpAu) carriers are also discussed.
Indexed as
Identifiers
40248930What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.